phenindione has been researched along with Myeloproliferative Disorders in 1 studies
Phenindione: An indandione that has been used as an anticoagulant. Phenindione has actions similar to WARFARIN, but it is now rarely employed because of its higher incidence of severe adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p234)
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salort, A | 1 |
| Seinturier, C | 1 |
| Molina, L | 1 |
| Lévèque, P | 1 |
| Imbert, B | 1 |
| Pernod, G | 1 |
1 other study available for phenindione and Myeloproliferative Disorders
| Article | Year |
|---|---|
[Recurrent deep vein thrombosis and myeloproliferative syndrom: emergence of JAK2 mutation five years after the initial event].
Topics: Adult; alpha-Thalassemia; Anticoagulants; Bone Marrow; Erythroblasts; Female; Humans; Janus Kinase 2 | 2014 |